
Sign up to save your podcasts
Or
• Switching from originator biological agents to biosimilars: what is the evidence and what are the issues? - http://rmdopen.bmj.com/content/3/2/e000492.
3.7
33 ratings
• Switching from originator biological agents to biosimilars: what is the evidence and what are the issues? - http://rmdopen.bmj.com/content/3/2/e000492.
38 Listeners
5 Listeners
51 Listeners
8 Listeners
5 Listeners
3 Listeners
2 Listeners
4 Listeners
9 Listeners
38 Listeners
14 Listeners
1 Listeners
51 Listeners
0 Listeners
6 Listeners
14 Listeners
3 Listeners
25 Listeners
24 Listeners